{"result": "{\n    \"title\": \"Cystic Fibrosis and Respiratory Health Community\",\n    \"summary\": \"The community focuses on the research and management of cystic fibrosis and bronchiectasis, involving key entities such as the Cystic Fibrosis Foundation, Arch Bronconeumol, and various researchers. These entities collaborate through research publications, guidelines, and support initiatives aimed at improving the understanding and treatment of these respiratory diseases.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of cystic fibrosis and bronchiectasis management, which significantly affects patient health outcomes.\",\n    \"findings\": [\n        {\n            \"summary\": \"Cystic Fibrosis Foundation's pivotal role\",\n            \"explanation\": \"The Cystic Fibrosis Foundation is a cornerstone entity in this community, dedicated to funding research and providing support for individuals with cystic fibrosis. It plays a crucial role in advancing treatment options and improving the quality of life for patients through comprehensive guidelines that include dietary and medical interventions. The foundation's commitment to research initiatives is vital for the ongoing development of effective management strategies for cystic fibrosis, making it a key player in the respiratory health landscape. [Data: Entities (1770); Relationships (2529, 3805, 3803)]\"\n        },\n        {\n            \"summary\": \"Arch Bronconeumol's contributions to respiratory health\",\n            \"explanation\": \"Arch Bronconeumol serves as a significant medical journal focused on respiratory diseases, including cystic fibrosis and bronchiectasis. It publishes a wide range of research articles and guidelines that contribute to the medical community's understanding of these conditions. The journal's role in disseminating research findings is crucial for informing clinical practices and advancing the field of respiratory health. Its publications are often referenced by other entities, highlighting its importance in the community. [Data: Entities (1824); Relationships (3633, 3908, 3920)]\"\n        },\n        {\n            \"summary\": \"Collaboration among researchers\",\n            \"explanation\": \"Numerous researchers, such as Oliveira G, De Gracia, and Martínez-García, are actively contributing to the understanding and treatment of cystic fibrosis and bronchiectasis. Their collaborative efforts, often published in reputable journals like the European Respiratory Journal and the American Journal of Respiratory and Critical Care Medicine, enhance the body of knowledge surrounding these diseases. This collaboration is essential for developing new treatment protocols and improving patient outcomes, showcasing the interconnectedness of research efforts within the community. [Data: Entities (1778, 1860, 1867); Relationships (3938, 3936, 3935)]\"\n        },\n        {\n            \"summary\": \"Guidelines and recommendations for cystic fibrosis management\",\n            \"explanation\": \"The Cystic Fibrosis Foundation provides comprehensive guidelines that encompass various aspects of managing cystic fibrosis, including nutritional support and medical interventions. These guidelines are critical for healthcare providers and patients alike, as they offer evidence-based recommendations that can significantly improve the quality of life for those affected by the disease. The foundation's collaboration with researchers ensures that these guidelines are continually updated based on the latest research findings. [Data: Relationships (3806, 3808, 3804)]\"\n        },\n        {\n            \"summary\": \"Research focus on bronchiectasis\",\n            \"explanation\": \"Bronchiectasis is another significant area of focus within this community, with multiple researchers contributing to its understanding and treatment. The European Respiratory Journal and Arch Bronconeumol publish numerous studies related to bronchiectasis, highlighting the importance of this condition in respiratory health. The ongoing research efforts aim to develop better management strategies and treatment options for patients suffering from bronchiectasis, which is often associated with other respiratory diseases. [Data: Entities (1866, 1861, 1864); Relationships (3940, 3944, 3946)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n----Reports-----\nid,full_content\r\n332,\"# Cystic Fibrosis and Bronchiectasis Research Community\n\nThe community is centered around the research and management of cystic fibrosis and bronchiectasis, involving key entities such as the Cystic Fibrosis Foundation, Arch Bronconeumol, and various researchers. These entities collaborate through research publications, guidelines, and support initiatives aimed at improving the understanding and treatment of these respiratory diseases.\n\n## Cystic Fibrosis Foundation's pivotal role\n\nThe Cystic Fibrosis Foundation is a cornerstone entity in this community, dedicated to funding research and providing support for individuals with cystic fibrosis. It plays a crucial role in advancing treatment options and improving the quality of life for patients through comprehensive guidelines that include dietary and medical interventions. The foundation's commitment to research initiatives is vital for the ongoing development of effective management strategies for cystic fibrosis, making it a key player in the respiratory health landscape. [Data: Entities (1770); Relationships (2529, 3805, 3803)]\n\n## Arch Bronconeumol's contributions to respiratory health\n\nArch Bronconeumol serves as a significant medical journal focused on respiratory diseases, including cystic fibrosis and bronchiectasis. It publishes a wide range of research articles and guidelines that contribute to the medical community's understanding of these conditions. The journal's role in disseminating research findings is crucial for informing clinical practices and advancing the field of respiratory health. Its publications are often referenced by other entities, highlighting its importance in the community. [Data: Entities (1824); Relationships (3633, 3908, 3920)]\n\n## Collaboration among researchers\n\nNumerous researchers, such as Oliveira G, De Gracia, and Martínez-García, are actively contributing to the understanding and treatment of cystic fibrosis and bronchiectasis. Their collaborative efforts, often published in reputable journals like the European Respiratory Journal and the American Journal of Respiratory and Critical Care Medicine, enhance the body of knowledge surrounding these diseases. This collaboration is essential for developing new treatment protocols and improving patient outcomes, showcasing the interconnectedness of research efforts within the community. [Data: Entities (1778, 1860, 1867); Relationships (3938, 3936, 3935)]\n\n## Guidelines and recommendations for cystic fibrosis management\n\nThe Cystic Fibrosis Foundation provides comprehensive guidelines that encompass various aspects of managing cystic fibrosis, including nutritional support and medical interventions. These guidelines are critical for healthcare providers and patients alike, as they offer evidence-based recommendations that can significantly improve the quality of life for those affected by the disease. The foundation's collaboration with researchers ensures that these guidelines are continually updated based on the latest research findings. [Data: Relationships (3806, 3808, 3804)]\n\n## Research focus on bronchiectasis\n\nBronchiectasis is another significant area of focus within this community, with multiple researchers contributing to its understanding and treatment. The European Respiratory Journal and Arch Bronconeumol publish numerous studies related to bronchiectasis, highlighting the importance of this condition in respiratory health. The ongoing research efforts aim to develop better management strategies and treatment options for patients suffering from bronchiectasis, which is often associated with other respiratory diseases. [Data: Entities (1866, 1861, 1864); Relationships (3940, 3944, 3946)]\"\r\n327,\"# Cystic Fibrosis and Nutritional Support Community\n\nThis community focuses on the intersection of cystic fibrosis, nutritional support, and related research. Key entities include enteral tube feeding, ivacaftor, and various researchers and organizations dedicated to improving the health outcomes of cystic fibrosis patients through nutritional interventions and treatment options.\n\n## Nutritional support is vital for cystic fibrosis management\n\nNutritional support, particularly through enteral tube feeding, is essential for patients with cystic fibrosis who cannot maintain adequate nutrition orally. This method ensures that patients receive the necessary nutrients to support their health and recovery, addressing the unique dietary needs associated with the condition. The relationship between enteral tube feeding and cystic fibrosis highlights the importance of tailored nutritional interventions in improving patient outcomes [Data: Entities (1951, 1821); Relationships (1157, 3915)].\n\n## Ivacaftor as a targeted treatment for cystic fibrosis\n\nIvacaftor is a medication specifically designed to correct the function of the RTFQ protein in patients with certain mutations, significantly enhancing lung function and nutritional status. Its role in the treatment landscape for cystic fibrosis underscores the importance of targeted therapies in managing the disease and improving the quality of life for affected individuals. The relationship between ivacaftor and cystic fibrosis illustrates the ongoing advancements in treatment options for this genetic disorder [Data: Entities (1815, 1821); Relationships (3884, 3882)].\n\n## Research contributions from key individuals\n\nResearchers like Olveira C and Morton A have made significant contributions to understanding the nutritional needs of cystic fibrosis patients. Their studies focus on enteral tube feeding and dietary supplementation, which are crucial for managing the health of individuals with this condition. The collaborative efforts of these researchers enhance the body of knowledge surrounding cystic fibrosis and inform best practices for nutritional care [Data: Entities (1831, 1895); Relationships (3913, 3914)].\n\n## The role of the Cochrane Database in cystic fibrosis research\n\nThe Cochrane Database serves as a vital resource for evidence-based information on cystic fibrosis, including systematic reviews that address nutritional interventions. This comprehensive collection aids healthcare professionals and researchers in making informed decisions regarding the management of cystic fibrosis, emphasizing the importance of high-quality research in improving patient care [Data: Entities (1942, 1821); Relationships (3911)].\n\n## Guidelines for nutritional care in cystic fibrosis\n\nOrganizations like ESPEN-ESPGHAN-ECFS provide essential guidelines for nutrition care specifically tailored for individuals with cystic fibrosis. These guidelines are crucial for ensuring that patients receive appropriate dietary management, which is vital for their growth and overall health. The relationship between cystic fibrosis and these guidelines highlights the structured approach needed to address the complex nutritional requirements of affected individuals [Data: Entities (1927, 1821); Relationships (3893, 3892)].\"\r\n\n\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n4869,ESPGHAN,\"The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) is an organization dedicated to the study and treatment of pediatric gastrointestinal and nutritional issues. It plays a significant role in advancing knowledge and practices in this field, including the publication of important documents such as a position paper on intestinal failure-associated liver disease. Additionally, ESPGHAN provides guidelines that address the nutritional needs of children, ensuring that healthcare professionals have access to the latest recommendations for managing pediatric patients.\",3\r\n1889,J CYST FIBROS,\"J Cyst Fibros is a journal dedicated to publishing research specifically on cystic fibrosis and related conditions. It serves as a platform for disseminating findings and advancements in the understanding and treatment of cystic fibrosis, contributing to the broader field of research associated with this genetic disorder.\",27\r\n1913,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,\"Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by increasing breathlessness. It is primarily caused by long-term exposure to irritating gases or particulate matter, with cigarette smoke being the most common source. Additionally, COPD can be related to cystic fibrosis and necessitates nutritional management to support the health of affected individuals.\",15\r\n1944,COPD,\"Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by breathing difficulties, primarily caused by long-term exposure to harmful substances. It is a common comorbidity in patients with cystic fibrosis, significantly impacting their respiratory health. COPD is a focus of various studies and treatments aimed at managing its symptoms and improving the quality of life for those affected.\",11\r\n1830,OLVEIRA G,\"Olveira G is a dedicated researcher with a focus on various aspects of nutrition and its implications for patients with cystic fibrosis and bronchiectasis. They have conducted significant studies examining fat-free mass depletion and inflammation in bronchiectasis patients, as well as investigating the psychological dimensions of these conditions, including depression and anxiety symptoms. Olveira G has authored several important publications, including a study on nutrition and cystic fibrosis published in Nutr Hosp, and has contributed to research on the effectiveness of home parenteral nutrition. Additionally, they have explored the impact of parenteral nutrition on in-hospital mortality, with findings published in Diabetes Care. Through their work, Olveira G has made valuable contributions to the understanding of nutrition's role in managing chronic respiratory conditions.\",9\r\n603,BRONCHIECTASIS,\"Bronchiectasis is a condition characterized by the abnormal and permanent dilation of the bronchi, which leads to chronic respiratory infections and inflammation. This condition can be associated with cystic fibrosis, significantly affecting lung function and often necessitating nutritional support for those affected. Additionally, bronchiectasis may also develop in patients with Klinefelter syndrome, highlighting its relevance in various pulmonary health contexts.\",8\r\n1887,DIOS,DIOS (Distal Intestinal Obstruction Syndrome) is a condition being studied in relation to cystic fibrosis.,4\r\n1956,LATIN AMERICAN THORACIC SOCIETY,The Latin American Thoracic Society (ALAT) is an organization that collaborates with SEPAR on guidelines for managing respiratory diseases.,3\r\n1955,SPANISH SOCIETY OF PULMONOLOGY AND THORACIC SURGERY,\"The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) is an organization focused on the diagnosis and management of respiratory diseases, including chronic obstructive pulmonary disease (COPD).\",3\r\n1885,HAUSER B,Hauser B is an author contributing to the study on DIOS and constipation in cystic fibrosis.,3\r\n1884,MUNCK A,Munck A is an author involved in a multicentre study on DIOS and constipation in cystic fibrosis.,3\r\n1886,WALKOWIAK J,Walkowiak J is an author participating in the multicentre study on DIOS and constipation in cystic fibrosis.,3\r\n1901,MAIZ L,\"Maiz L is a researcher and author who has made significant contributions to the field of bronchiectasis. They studied the prevalence of nontuberculous mycobacteria in patients with bronchiectasis, enhancing the understanding of this condition. Additionally, Maiz L has contributed to the diagnosis and treatment of bronchiectasis, furthering knowledge and practices in managing this respiratory disease.\",2\r\n1894,ARIS RM,Aris RM is an author involved in the European cystic fibrosis bone mineralisation guidelines.,1\r\n1910,BARRETO C,Barreto C is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1892,BIANCHI ML,Bianchi ML is an author involved in the European cystic fibrosis bone mineralisation guidelines.,1\r\n1911,BILTON D,Bilton D is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1907,CONWAY S,Conway S is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1904,CRUZ I,Cruz I is an author who studied depression and anxiety symptoms in bronchiectasis.,1\r\n1898,DE GRACIA J,De Gracia J is an author who contributed to the diagnosis and treatment of bronchiectasis.,1\r\n1903,DORADO A,Dorado A is an author who studied depression and anxiety symptoms in bronchiectasis.,1\r\n1908,ELBORN S,Elborn S is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1893,GARABÉDIAN M,Garabédian M is an author involved in the European cystic fibrosis bone mineralisation guidelines.,1\r\n1902,GASPAR I,Gaspar I is an author who studied depression and anxiety symptoms in bronchiectasis.,1\r\n1900,GIRON R,Giron R is an author who contributed to the diagnosis and treatment of bronchiectasis.,1\r\n1896,HARDIN DS,Hardin DS is an author involved in the European cystic fibrosis bone mineralisation guidelines.,1\r\n1909,HEIJERMAN H,Heijerman H is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1891,SERMET-GAUDELUS I,Sermet-Gaudelus I is an author involved in the European cystic fibrosis bone mineralisation guidelines.,1\r\n1897,VENDRELL M,Vendrell M is an author who contributed to the diagnosis and treatment of bronchiectasis.,1\r\n1899,MARTINEZ MA,Martinez MA is an author who contributed to the diagnosis and treatment of bronchiectasis.,1\r\n1905,SORIGUER F,Soriguer F is an author who studied depression and anxiety symptoms in bronchiectasis.,1\r\n1906,KEREM E,Kerem E is an author involved in the standards of care for patients with cystic fibrosis.,1\r\n1929,ANEMIA,\"Anemia is a condition that can affect patients with chronic obstructive pulmonary disease, impacting their overall health and nutritional needs.\",2\r\n1914,NUTRITIONAL DEPLETION,\"Nutritional depletion refers to a state where an individual lacks essential nutrients, which can significantly impact health, particularly in patients with chronic diseases like COPD.\",2\r\n1919,BOLTON CE,Bolton CE is a researcher who investigated the loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.,1\r\n1923,CEBRON LIPOVEC N,Cebron Lipovec N is a researcher who studied the prevalence of metabolic syndrome in chronic obstructive pulmonary disease.,1\r\n1917,CELL BR,Celli BR is a researcher known for work on the Body-Mass Index and its relation to chronic obstructive pulmonary disease.,1\r\n1915,METABOLIC SYNDROME,\"Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, often associated with obesity and insulin resistance.\",1\r\n1926,SCHOLS AMWJ,Schols AMWJ is an author known for researching the impact of nutritional status on patients with Chronic Obstructive Pulmonary Disease (COPD).,1\r\n1918,VERMEEREN MAP,Vermeeren MAP is a researcher who studied the prevalence of nutritional depletion in patients with COPD.,1\r\n1920,VILARÓ J,Vilaró J is a researcher who examined global muscle dysfunction as a risk factor for hospital readmission due to COPD exacerbations.,1\r\n1922,SPRUIT MA,Spruit MA is a researcher who contributed to the official statement on pulmonary rehabilitation by the American Thoracic Society and European Respiratory Society.,1\r\n1925,GRAAT-VERBOOM L,Graat-Verboom L is a researcher who conducted a systematic review on osteoporosis in COPD.,1\r\n1846,SOLER-CATALUÑA JJ,\"Soler-Cataluña JJ is a researcher known for his contributions to the field of chronic obstructive pulmonary disease (COPD). He has conducted studies on the predictive value of mid-arm muscle area in relation to mortality in COPD patients. Additionally, he is recognized as an author of the Spanish guidelines for the treatment of COPD, which were published in the journal Arch Bronconeumol.\",1\r\n1888,J PEDIATR GASTROENTEROL NUTR,\"The \"\"Journal of Pediatric Gastroenterology and Nutrition\"\" is a specialized publication that focuses on research related to pediatric gastroenterology. It serves as a platform for disseminating important findings in the field, including studies on conditions such as cystic fibrosis. Notably, the journal published a position paper addressing intestinal failure-associated liver disease, highlighting its role in advancing knowledge and understanding of critical issues affecting pediatric patients.\",10\r\n5297,HOJSAK I,Hojsak I is a co-author of the position paper on intestinal failure-associated liver disease.Hojsak I is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.,2\r\n1950,COLLINS PF,Collins PF is a researcher who has conducted systematic reviews on nutritional support in chronic obstructive pulmonary disease.,1\r\n1948,RESPIROLOGY,Respirology is a journal that publishes research on respiratory health and diseases.,1\r\n1959,EXERCISE TRAINING,Exercise training is a therapeutic intervention studied for its benefits in improving exercise capacity in patients with chronic respiratory diseases.,1\r\n5315,BRAEGGER C,Braegger C is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.,1\r\n5316,BRONSKY J,Bronsky J is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.,1\r\n5303,CALKINS KL,Calkins KL is a co-author of a study on pediatric intestinal failure associated liver disease.,1\r\n5317,CAMPLOY C,Campoy C is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.,1\r\n5318,DOMELLÖF M,Domellöf M is a co-author of a systematic review and meta-analysis on intravenous lipid emulsions and risk of hepatotoxicity in infants and children.,1\r\n5305,MERCER DF,Mercer DF is a co-author of a study on hepatic fibrosis in children treated with intravenous fish oil emulsion.,1\r\n4599,BALLESTEROS-POMAR MD,\"Ballesteros-Pomar MD is an author who contributed to the study on parenteral nutrition-associated hyperglycemia, published in Diabetes Care.\",1\r\n4598,CABREJAS-GÓMEZ C,\"Cabrejas-Gómez C is an author who studied parenteral nutrition-associated hyperglycemia, published in Diabetes Care.\",1\r\n4597,OCÓN J,\"Ocón J is an author involved in the research on parenteral nutrition-associated hyperglycemia, published in Diabetes Care.\",1\r\n4596,TAPIA MJ,\"Tapia MJ is an author who contributed to the study on parenteral nutrition-associated hyperglycemia, published in Diabetes Care.\",1\r\n4600,VIDAL-CASARIEGO A,\"Vidal-Casariego A is an author involved in the research on parenteral nutrition-associated hyperglycemia, published in Diabetes Care.\",1\r\n1921,ONEN ZP,Onen ZP is a researcher who analyzed factors related to mortality in patients with bronchiectasis.,1\r\n1924,DIEHL N,Diehl N is a researcher who examined the prevalence of osteopenia and osteoporosis in patients with noncystic fibrosis bronchiectasis.,1\r\n1930,ERTHROPOIESIS STIMULATING AGENTS,Erythropoiesis stimulating agents are treatments used to correct anemia in patients with chronic obstructive pulmonary disease.,1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n6061,NUTRICIÓN PEDIÁTRICA,ESPGHAN,ESPGHAN provides guidelines that inform the recommendations in NUTRICIÓN PEDIÁTRICA,180\r\n3910,CYSTIC FIBROSIS,J CYST FIBROS,J Cyst Fibros focuses on research specifically related to cystic fibrosis,64\r\n3896,CYSTIC FIBROSIS,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,\"Chronic obstructive pulmonary disease can occur in patients with cystic fibrosis, requiring tailored nutritional care\",52\r\n3913,CYSTIC FIBROSIS,COPD,\"COPD is a common comorbidity in cystic fibrosis patients, impacting their overall health\",48\r\n3894,CYSTIC FIBROSIS,OLVEIRA G,Olveira G is involved in research that addresses nutritional needs in patients with cystic fibrosis,46\r\n2007,BRONCHIECTASIS,CYSTIC FIBROSIS,\"Bronchiectasis is a common complication of cystic fibrosis, necessitating specific nutritional interventions\",45\r\n3891,CYSTIC FIBROSIS,DIOS,DIOS is a condition that occurs in patients with cystic fibrosis,41\r\n3918,CYSTIC FIBROSIS,LATIN AMERICAN THORACIC SOCIETY,The Latin American Thoracic Society collaborates on guidelines for cystic fibrosis management,40\r\n3917,CYSTIC FIBROSIS,SPANISH SOCIETY OF PULMONOLOGY AND THORACIC SURGERY,The Spanish Society of Pulmonology and Thoracic Surgery provides guidelines for the management of cystic fibrosis,40\r\n3926,OLVEIRA G,J CYST FIBROS,Olveira G's research is published in the Journal of Cystic Fibrosis,36\r\n4014,COPD,NUTRIENTS,Nutrients publishes research related to dietary practices that can impact the health of COPD patients,34\r\n1999,OSTEOPOROSIS,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,\"Chronic obstructive pulmonary disease can lead to osteoporosis, increasing the risk of fractures in affected individuals\",33\r\n3968,HAUSER B,J CYST FIBROS,Hauser B's research is published in the Journal of Cystic Fibrosis,30\r\n3965,MUNCK A,J CYST FIBROS,Munck A's research is published in the Journal of Cystic Fibrosis,30\r\n3971,WALKOWIAK J,J CYST FIBROS,Walkowiak J's research is published in the Journal of Cystic Fibrosis,30\r\n3983,J CYST FIBROS,MORTON A,Morton A's research is published in the Journal of Cystic Fibrosis,29\r\n3989,J CYST FIBROS,MAIZ L,Maiz L's research is published in the Journal of Cystic Fibrosis,29\r\n3933,OLVEIRA C,J CYST FIBROS,Olveira C's research is published in the Journal of Cystic Fibrosis,29\r\n1238,NUTRITIONAL STATUS,COPD,Nutritional status is critical for managing patients with COPD,29\r\n3982,J CYST FIBROS,ARIS RM,Aris RM's research is published in the Journal of Cystic Fibrosis,28\r\n3998,J CYST FIBROS,BARRETO C,Barreto C's research is published in the Journal of Cystic Fibrosis,28\r\n3980,J CYST FIBROS,BIANCHI ML,Bianchi ML's research is published in the Journal of Cystic Fibrosis,28\r\n3999,J CYST FIBROS,BILTON D,Bilton D's research is published in the Journal of Cystic Fibrosis,28\r\n3995,J CYST FIBROS,CONWAY S,Conway S's research is published in the Journal of Cystic Fibrosis,28\r\n3992,J CYST FIBROS,CRUZ I,Cruz I's research is published in the Journal of Cystic Fibrosis,28\r\n3986,J CYST FIBROS,DE GRACIA J,De Gracia J's research is published in the Journal of Cystic Fibrosis,28\r\n3991,J CYST FIBROS,DORADO A,Dorado A's research is published in the Journal of Cystic Fibrosis,28\r\n3996,J CYST FIBROS,ELBORN S,Elborn S's research is published in the Journal of Cystic Fibrosis,28\r\n3981,J CYST FIBROS,GARABÉDIAN M,Garabédian M's research is published in the Journal of Cystic Fibrosis,28\r\n3990,J CYST FIBROS,GASPAR I,Gaspar I's research is published in the Journal of Cystic Fibrosis,28\r\n3988,J CYST FIBROS,GIRON R,Giron R's research is published in the Journal of Cystic Fibrosis,28\r\n3984,J CYST FIBROS,HARDIN DS,Hardin DS's research is published in the Journal of Cystic Fibrosis,28\r\n3997,J CYST FIBROS,HEIJERMAN H,Heijerman H's research is published in the Journal of Cystic Fibrosis,28\r\n3979,J CYST FIBROS,SERMET-GAUDELUS I,Sermet-Gaudelus I's research is published in the Journal of Cystic Fibrosis,28\r\n3985,J CYST FIBROS,VENDRELL M,Vendrell M's research is published in the Journal of Cystic Fibrosis,28\r\n3987,J CYST FIBROS,MARTINEZ MA,Martinez MA's research is published in the Journal of Cystic Fibrosis,28\r\n3993,J CYST FIBROS,SORIGUER F,Soriguer F's research is published in the Journal of Cystic Fibrosis,28\r\n3994,J CYST FIBROS,KEREM E,Kerem E's research is published in the Journal of Cystic Fibrosis,28\r\n3932,OLVEIRA G,NUTRICIÓN PARENTERAL DOMICILIARIA,Olveira G has researched the effectiveness of home parenteral nutrition,27\r\n4913,HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,ESPGHAN,Hospital Universitario 12 de Octubre may follow guidelines set by ESPGHAN for pediatric nutrition and gastrointestinal health,24\r\n1976,KLINEFELTER SYNDROME,BRONCHIECTASIS,Klinefelter syndrome patients are at increased risk for bronchiectasis,21\r\n3925,ARCH BRONCONEUMOL,COPD,\"Arch Bronconeumol publishes research related to respiratory diseases, including COPD\",20\r\n3788,OSTEOPENIA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Patients with chronic obstructive pulmonary disease are at increased risk for osteopenia due to factors like inactivity and nutritional deficiencies,18\r\n1231,NUTRITIONAL SUPPLEMENTATION,COPD,Nutritional supplementation is a key strategy in managing patients with COPD to enhance their nutritional status and overall health,18\r\n4010,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,ANEMIA,\"Anemia is prevalent among patients with chronic obstructive pulmonary disease, affecting their treatment and management\",17\r\n4000,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NUTRITIONAL DEPLETION,\"Nutritional depletion is a common issue faced by patients with chronic obstructive pulmonary disease, impacting their overall health and recovery\",17\r\n2005,BRONCHIECTASIS,OLVEIRA G,Olveira G's research on fat-free mass depletion is pertinent to bronchiectasis,17\r\n4005,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,BOLTON CE,Bolton CE's studies link loss of fat-free mass and bone mineral density to chronic obstructive pulmonary disease,16\r\n4008,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,CEBRON LIPOVEC N,Cebron Lipovec N's research on metabolic syndrome is relevant to chronic obstructive pulmonary disease,16\r\n4003,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,CELL BR,Celli BR's work relates to the Body-Mass Index and its implications for chronic obstructive pulmonary disease,16\r\n4001,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,METABOLIC SYNDROME,\"There is a significant association between metabolic syndrome and chronic obstructive pulmonary disease, impacting patient management\",16\r\n4002,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SCHOLS AMWJ,Schols AMWJ's research focuses on body composition and its impact on mortality in chronic obstructive pulmonary disease,16\r\n4004,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,VERMEEREN MAP,Vermeeren MAP's research addresses nutritional depletion in patients with chronic obstructive pulmonary disease,16\r\n4006,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,VILARÓ J,Vilaró J's work highlights global muscle dysfunction as a risk factor for COPD exacerbations,16\r\n4007,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SPRUIT MA,Spruit MA's contributions to pulmonary rehabilitation are significant for managing chronic obstructive pulmonary disease,16\r\n4009,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,GRAAT-VERBOOM L,Graat-Verboom L's systematic review on osteoporosis is important for understanding its impact on COPD,16\r\n3934,SOLER-CATALUÑA JJ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Soler-Cataluña JJ's research indicates that mid-arm muscle area is a predictor of mortality in chronic obstructive pulmonary disease,16\r\n4016,COPD,SPANISH SOCIETY OF PULMONOLOGY AND THORACIC SURGERY,The Spanish Society of Pulmonology and Thoracic Surgery focuses on the management and treatment of COPD,14\r\n4017,COPD,LATIN AMERICAN THORACIC SOCIETY,The Latin American Thoracic Society also addresses COPD in its guidelines and research,14\r\n3967,HAUSER B,J PEDIATR GASTROENTEROL NUTR,Hauser B's research is published in the Journal of Pediatric Gastroenterology and Nutrition,13\r\n3964,MUNCK A,J PEDIATR GASTROENTEROL NUTR,Munck A's research is published in the Journal of Pediatric Gastroenterology and Nutrition,13\r\n3970,WALKOWIAK J,J PEDIATR GASTROENTEROL NUTR,Walkowiak J's research is published in the Journal of Pediatric Gastroenterology and Nutrition,13\r\n2008,BRONCHIECTASIS,HMB,HMB supplementation has been shown to improve body composition and health-related quality of life in patients with bronchiectasis,13\r\n3789,GOLD STAGE,COPD,\"The GOLD stage classification is used to assess the severity of COPD, which is relevant for cystic fibrosis patients\",13\r\n3972,J PEDIATR GASTROENTEROL NUTR,HOJSAK I,Hojsak I's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition,12\r\n4013,COPD,COLLINS PF,Collins PF has conducted systematic reviews on nutritional support for patients with COPD,12\r\n4015,COPD,RESPIROLOGY,\"Respirology publishes research on various aspects of COPD, including nutritional interventions\",12\r\n4018,COPD,EXERCISE TRAINING,Exercise training is a recommended intervention to improve exercise capacity in COPD patients,12\r\n3975,J PEDIATR GASTROENTEROL NUTR,BRAEGGER C,Braegger C's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n3976,J PEDIATR GASTROENTEROL NUTR,BRONSKY J,Bronsky J's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n3973,J PEDIATR GASTROENTEROL NUTR,CALKINS KL,Calkins KL's study on pediatric intestinal failure was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n3977,J PEDIATR GASTROENTEROL NUTR,CAMPLOY C,Campoy C's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n3978,J PEDIATR GASTROENTEROL NUTR,DOMELLÖF M,Domellöf M's systematic review on intravenous lipid emulsions was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n3974,J PEDIATR GASTROENTEROL NUTR,MERCER DF,Mercer DF's study on hepatic fibrosis was published in Journal of Pediatric Gastroenterology and Nutrition,11\r\n2002,BRONCHIECTASIS,NUTRITIONAL DEPLETION,Nutritional depletion is often observed in patients with bronchiectasis due to chronic infections and inflammation,10\r\n3930,OLVEIRA G,BALLESTEROS-POMAR MD,\"Olveira G and Ballesteros-Pomar MD are both authors who studied parenteral nutrition-associated hyperglycemia, indicating a collaborative or thematic relationship\",10\r\n2004,BRONCHIECTASIS,MAIZ L,Maiz L's study on nontuberculous mycobacteria is relevant to bronchiectasis patients,10\r\n3929,OLVEIRA G,CABREJAS-GÓMEZ C,\"Olveira G and Cabrejas-Gómez C are both authors who studied parenteral nutrition-associated hyperglycemia, indicating a collaborative or thematic relationship\",10\r\n3928,OLVEIRA G,OCÓN J,\"Olveira G and Ocón J are both authors who studied parenteral nutrition-associated hyperglycemia, indicating a collaborative or thematic relationship\",10\r\n3927,OLVEIRA G,TAPIA MJ,\"Olveira G and Tapia MJ are both authors who studied parenteral nutrition-associated hyperglycemia, indicating a collaborative or thematic relationship\",10\r\n3931,OLVEIRA G,VIDAL-CASARIEGO A,\"Olveira G and Vidal-Casariego A are both authors who studied parenteral nutrition-associated hyperglycemia, indicating a collaborative or thematic relationship\",10\r\n2003,BRONCHIECTASIS,ONEN ZP,Onen ZP's research focuses on mortality factors in patients with bronchiectasis,9\r\n2006,BRONCHIECTASIS,DIEHL N,Diehl N's work on osteopenia and osteoporosis is related to patients with bronchiectasis,9\r\n3963,MUNCK A,DIOS,Munck A is involved in the study that defines DIOS in cystic fibrosis,7\r\n3966,HAUSER B,DIOS,Hauser B is involved in the study that defines DIOS in cystic fibrosis,7\r\n3969,WALKOWIAK J,DIOS,Walkowiak J is involved in the study that defines DIOS in cystic fibrosis,7\r\n4037,SPANISH SOCIETY OF PULMONOLOGY AND THORACIC SURGERY,LATIN AMERICAN THORACIC SOCIETY,Both organizations collaborate on guidelines for the diagnosis and management of respiratory diseases,6\r\n6251,ESPGHAN,HOJSAK I,Hojsak I contributed to the position paper published by ESPGHAN,5\r\n4011,ANEMIA,ERTHROPOIESIS STIMULATING AGENTS,Erythropoiesis stimulating agents are used to treat anemia in patients with chronic obstructive pulmonary disease,3\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}